TY - JOUR
T1 - Diagnosis, treatment and post-release monitoring of an eastern black rat snake (Pantherophis alleghaniensis) with ophidiomycosis and traumatic injuries
AU - Veilleux, Jacob
AU - Dombrowski, Daniel Steven
AU - Allender, Matthew C.
AU - Lewbart, Gregory
N1 - Publisher Copyright:
© British Veterinary Association 2020. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2020/4/28
Y1 - 2020/4/28
N2 - Ophidiomycosis, historically known as snake fungal disease, is caused by Ophidiomyces ophiodiicola and has been reported in over 30 species of snakes. In July 2015, an adult female eastern black rat snake (Pantherophis alleghaniensis) was found at Prairie Ridge EcoStation, a North Carolina Museum of Natural Sciences (NCMNS) field site in Raleigh, NC, with traumatic lesions consistent with injuries caused by landscaping equipment. The snake was brought to NCMNS Veterinary Services and tested positive via dermal swabs for O ophiodiicola on quantitative PCR (qPCR). The snake was treated with terbinafine (Terbinafine, 250 mg; InvaGen Pharmaceuticals, Hauppauge, NY, USA) nebulised at 2 mg/ml for 30 min every 24 hours for 30 days, and tested negative on further swabs for O ophiodiicola on qPCR before release. From April 2016 to November 2018, the snake was tracked via radio telemetry with physical examinations, bloodwork and qPCR swabs conducted multiple times a year.
AB - Ophidiomycosis, historically known as snake fungal disease, is caused by Ophidiomyces ophiodiicola and has been reported in over 30 species of snakes. In July 2015, an adult female eastern black rat snake (Pantherophis alleghaniensis) was found at Prairie Ridge EcoStation, a North Carolina Museum of Natural Sciences (NCMNS) field site in Raleigh, NC, with traumatic lesions consistent with injuries caused by landscaping equipment. The snake was brought to NCMNS Veterinary Services and tested positive via dermal swabs for O ophiodiicola on quantitative PCR (qPCR). The snake was treated with terbinafine (Terbinafine, 250 mg; InvaGen Pharmaceuticals, Hauppauge, NY, USA) nebulised at 2 mg/ml for 30 min every 24 hours for 30 days, and tested negative on further swabs for O ophiodiicola on qPCR before release. From April 2016 to November 2018, the snake was tracked via radio telemetry with physical examinations, bloodwork and qPCR swabs conducted multiple times a year.
KW - Biosecurity
KW - Fungal diseases
KW - Pcr
KW - Snakes
KW - Wildlife
UR - http://www.scopus.com/inward/record.url?scp=85084388615&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084388615&partnerID=8YFLogxK
U2 - 10.1136/vetreccr-2019-000954
DO - 10.1136/vetreccr-2019-000954
M3 - Article
AN - SCOPUS:85084388615
SN - 2052-6121
VL - 8
JO - Veterinary Record Case Reports
JF - Veterinary Record Case Reports
IS - 2
M1 - e000954
ER -